SUNPHARMA

SUN PHARMACEUTICAL INDUSTRIES

Large Cap BSE: 524715 NSE: SUNPHARMA
₹1033.55
-5.85 (-0.56%)
As on 06 December, 2022 | 22:12

Sun Pharmaceutical Industries Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SUN PHARMACEUTICAL INDUSTRIES

Start SIP

Sun Pharmaceutical Industries Share Price

Sun Pharmaceutical Industries Share Returns

  • Over 1 Month -0.61%
  • Over 3 Month 16.42%
  • Over 6 Month 20.21%
  • Over 1 Year 40.21%

Sun Pharmaceutical Industries Key Statistics

P/E Ratio 60.4
PEG Ratio -1.8
Market Cap Cr 247,983
Price to Book Ratio 4.9
EPS -5.6
Dividend 1
Relative Strength Index 58.13
Money Flow Index 66.72
MACD Signal 14.22
Average True Range 17.75

Sun Pharmaceutical Industries Investment Rating

  • Master Rating:
  • Sun Pharm.Industries has an operating revenue of Rs. 41,023.86 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 14% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 38 which is a POOR score indicating inconsistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Sun Pharmaceutical Industries Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 5,2854,8623,9883,7714,1433,3133,119
Operating Expenses Qtr Cr 3,6223,4833,0073,1143,2792,6942,479
Operating Profit Qtr Cr 1,6631,4501,000656864631680
Depreciation Qtr Cr 384375354355334151152
Interest Qtr Cr 93879185104106103
Tax Qtr Cr 15254865-981344
Net Profit Qtr Cr 1,2131,012-1,286515809419327

Sun Pharmaceutical Industries Technicals

EMA & SMA

Current Price
1033.55
-5.85 (-0.56%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1026.94
  • 50 Day
  • 995.73
  • 100 Day
  • 958.2
  • 200 Day
  • 911.48
  • 20 Day
  • 1025.11
  • 50 Day
  • 993.98
  • 100 Day
  • 942.68
  • 200 Day
  • 908.98

Sun Pharmaceutical Industries Resistance and Support

PIVOT
₹1038.7
Resistance
First Resistance 1046.66
Second Resistance 1053.91
Third Resistance 1061.85
RSI 58.13
MFI 66.72
MACD Single Line 14.22
MACD 13.03
Support
First Resistance 1031.45
Second Resistance 1023.5
Third Resistance 1016.25

Sun Pharmaceutical Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,345,499 173,402,741 73.93
Week 2,191,531 143,939,730 65.68
1 Month 2,016,542 128,877,167 63.91
6 Month 2,908,642 163,611,123 56.25

Sun Pharmaceutical Industries Result Highlights

Sun Pharmaceutical Industries Synopsis

NSE-Medical-Generic Drugs

Sun Pharma. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 15585.98 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2022. Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050.
Market Cap 248,331
Sales 17,996
Shares in Float 110.37
No of funds 1015
Yield 0.96
Book Value 10.14
U/D Vol ratio 1.3
LTDebt / Equity 20
Alpha 0.12
Beta 0.62

Sun Pharmaceutical Industries

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 54.48%54.48%54.48%
Mutual Funds 12.22%11.84%11.63%
Insurance Companies 6.36%7.52%7.94%
Foreign Portfolio Investors 16%14.95%14.44%
Financial Institutions/ Banks 0.02%0.22%0.37%
Individual Investors 5.91%6.31%6.49%
Others 5.01%4.68%4.65%

Sun Pharmaceutical Industries Management

Name Designation
Mr. Israel Makov Chairman, Non Ind & Non Exe Director
Mr. Dilip S Shanghvi Managing Director
Mr. Sailesh T Desai Whole Time Director
Mr. Kalyanasundaram Subramanian Whole Time Director
Mr. Sudhir V Valia Non Exe.Non Ind.Director
Dr. Pawan Goenka Non Exe. & Ind. Director
Mr. Rama Bijapurkar Non Exe. & Ind. Director
Mr. Gautam Doshi Ind. Non-Executive Director

Sun Pharmaceutical Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Sun Pharmaceutical Industries Corporate Action

Date Purpose Remarks
2022-11-01 Quarterly Results
2022-07-29 Quarterly Results
2022-05-30 Audited Results & Final Dividend
2022-01-31 Quarterly Results & Interim Dividend
2021-11-02 Quarterly Results
Date Purpose Remarks
2022-08-22 FINAL Rs.3.00 per share(300%)Final Dividend
2022-02-10 INTERIM Rs.7.00 per share(700%)Interim Dividend
2021-02-10 INTERIM Rs.5.50 per share(550%)Interim Dividend

Sun Pharmaceutical Industries MF Shareholding

Name Amount(cr)
SBI Nifty 50 ETF 151468
SBI S&P BSE Sensex ETF 83302
SBI Equity Hybrid Fund Regular Payout Inc Dist cum Cap Wdrl 56730
HDFC Balanced Advantage Fund Growth 49709
ICICI Prudential Balanced Advantage Fund Growth 44002

Sun Pharmaceutical Industries FAQs

What is Share Price of Sun Pharmaceutical Industries ?

Sun Pharmaceutical Industries share price is ₹1033 As on 06 December, 2022 | 21:58

What is the Market Cap of Sun Pharmaceutical Industries ?

The Market Cap of Sun Pharmaceutical Industries is ₹247983.3 Cr As on 06 December, 2022 | 21:58

What is the P/E ratio of Sun Pharmaceutical Industries ?

The P/E ratio of Sun Pharmaceutical Industries is 60.4 As on 06 December, 2022 | 21:58

What is the PB ratio of Sun Pharmaceutical Industries ?

The PB ratio of Sun Pharmaceutical Industries is 4.9 As on 06 December, 2022 | 21:58

What is the future of Sun Pharmaceutical Industries (Sun Pharma)?

Sun Pharmaceutical Industries (Sun Pharma) has an operating revenue of INR 36,704.43 Cr. on a trailing 12-month basis. Annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay. Institutional holding has gone up in the last reported quarter is a positive sign. Analyst Recommendation on Sun Pharmaceutical Industries (Sun Pharma): HOLD

Who is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma)?

Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries (Sun Pharma).

What is the ROE of Sun Pharmaceutical Industries (Sun Pharma)?

The ROE of Sun Pharmaceutical Industries (Sun Pharma) is 6% which is fair but needs improvement.

Is Sun Pharmaceutical Industries (Sun Pharma) Debt to Equity Ratio?

Sun Pharmaceutical Industries (Sun Pharma) has a reasonable debt to equity of 2%, which signals a healthy balance sheet.

What is the PE ratio of Sun Pharmaceutical Industries (Sun Pharma)?

The PE ratio of Sun Pharmaceutical Industries (Sun Pharma) is 81.5.

Q2FY23